BenzingaOctober 22, 2026 at 3:25 AM NY5 Days Ago
Baird Maintains Neutral on Elevance Health, Raises Price Target to $406
Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $393 to $406.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
